25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel

被引:16
作者
Grieve, Andrew P. [1 ]
机构
[1] Kings Coll London, Dept Publ Hlth Sci, London 3C1 3QD, England
关键词
bayesian methods; pharmaceutical R & D bioequivalence; LD50; crossover; pharmacoeconomics;
D O I
10.1002/pst.315
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Twenty-five years ago the use of Bayesian methods in Pharmaceutical R&D was non-existent. Today that is no longer true. In this paper I describe my own personal journey along the road of discovery of Bayesian methods to routine use in the pharmaceutical industry. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:261 / 281
页数:21
相关论文
共 101 条
[11]  
Berry D. A., 1985, BANDIT PROBLEMS SEQU
[12]  
Berry D.A., 2002, Case Studies in Bayesian Statistics, V5, P99
[13]   THE CE PLANE - A GRAPHIC REPRESENTATION OF COST-EFFECTIVENESS [J].
BLACK, WC .
MEDICAL DECISION MAKING, 1990, 10 (03) :212-214
[14]   PROVING THE NULL HYPOTHESIS IN CLINICAL-TRIALS [J].
BLACKWELDER, WC .
CONTROLLED CLINICAL TRIALS, 1982, 3 (04) :345-353
[15]  
Box GE., 2011, BAYESIAN INFERENCE S
[16]   SAMPLING AND BAYES INFERENCE IN SCIENTIFIC MODELING AND ROBUSTNESS [J].
BOX, GEP .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 1980, 143 :383-430
[17]  
BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324
[18]   MODEL UNCERTAINTY, DATA MINING AND STATISTICAL-INFERENCE [J].
CHATFIELD, C .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 1995, 158 :419-466